We focus on identifying novel small-molecule drugs that target key proteins implicated in cancer and inflammatory diseases. Our approach combines high-throughput screening with advanced computational methods to discover promising therapeutic candidates.
We focus on designing and syhthesizing innovative drug derivatives, optimizing their efficacy and safety. We leverage structure-activity relationship (SAR) studies to refine molecular structures and enhance pharmacological properties.
Using state-of-the-art proteomic technologies, we analyze protein expression, modifications, and interactions. This helps us understand the molecular mechanisms underlying diseases and identify new therapeutic targets.
Our biotechnology research focuses on developing and applying biotechnological tools to improve drug delivery, enhance therapeutic efficacy, and engineer novel biologics. We integrate molecular biology, bioengineering, and bioprocessing techniques to advance our drug development pipeline.